Treasury Chief Reeves Plans Focused Action on Household Expenses in Upcoming Budget
Treasury head Rachel Reeves has announced she is preparing "specific action to deal with cost of living challenges" in the upcoming Budget.
Speaking to the BBC, she stated that curbing inflation is a joint duty of both the administration and the Bank of England.
The United Kingdom's inflation rate is forecast to be the highest among the Group of Seven industrialized countries this calendar year and the following year.
Potential Utility Cost Interventions
It is understood the government could intervene to bring down energy bills, such as by slashing the present 5% rate of value-added tax applied on energy supplies.
A further approach is to reduce some of the policy costs currently added to household expenses.
Fiscal Constraints and Analyst Predictions
The government will receive the latest assessment from the official forecaster, the OBR, on the start of the week, which will show how much space there is for these measures.
The view from the majority of economists is that the Chancellor will have to announce higher taxes or expenditure reductions in order to meet her self-imposed debt limits.
Previously on the same day, estimates indicated there was a ÂŁ22 billion gap for the chancellor to fill, which is at the lower end of expectations.
"There's a collective job between the Bank of England and the government to further reduce some of the drivers of inflation," Reeves informed the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.
Revenue Pledges and Global Concerns
While a great deal of the attention has been on probable tax increases, the chancellor said the latest information from the OBR had not altered her vow to election pledges not to increase rates on earnings tax, sales tax or National Insurance.
She attributed an "uncertain world" with growing geopolitical and commercial issues for the fiscal tax moves, likely to be directed on those "with the broadest shoulders."
International Economic Disputes
Addressing concerns about the UK's trade ties with China she said: "The UK's national security always are paramount."
Recent announcement by China to strengthen export controls on rare earths and other materials that are key for advanced tech manufacturing led US President the US President to suggest an additional 100% import tax on goods from the Asian country, raising the prospect of an full-scale commercial conflict between the two global powers.
The American finance chief called the Chinese decision "commercial pressure" and "a international production control attempt."
Asked about considering the US offer to join its dispute with the Asian nation, Reeves said she was "deeply worried" by China's actions and called on the Beijing authorities "not to put up barriers and restrict access."
She said the action was "damaging for the global economy and causes further headwinds."
"I believe there are areas where we need to address Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other sectors of the economic system. We've got to achieve that equilibrium appropriate."
The chancellor also stated she was working with international partners "on our own critical minerals approach, so that we are reduced dependence."
NHS Medicine Costs and Investment
Reeves also admitted that the cost the National Health Service spends on medicines could rise as a result of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and capital.
Some of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or scrapping operations in the UK, with several blaming the modest returns they are getting.
Last month, the Science Minister said the price the NHS pays for medicines would must rise to stop businesses and drug research funding departing from the United Kingdom.
Reeves informed media: "We have seen because of the payment system, that clinical trials, new drugs have not been provided in the UK in the way that they are in other European countries."
"Our aim is to guarantee that people getting treatment from the National Health Service are able to access the finest life-saving medicines in the world. And so we are examining all of that, and... looking to secure more capital into the UK."